OneMedNet Expands into Asia-Pacific with Mediplexus Partnership

  • OneMedNet signed its 11th channel partner agreement with Mediplexus, a subsidiary of C&R Research, to expand into Korea and the Asia-Pacific region.
  • The deal will supply OneMedNet’s U.S.-sourced Real World Data (RWD) to Mediplexus, broadening the scope of collaboration over a one-year initial engagement.
  • OneMedNet’s iRWD™ network exceeds 90 million patient journeys, 270 million studies, and 2,300 healthcare partner sites.
  • The global RWE solutions market is projected to grow from USD 5.4 billion in 2025 to USD 10.8 billion by 2030.

OneMedNet’s partnership with Mediplexus is strategic as the global regulatory environment increasingly accepts Real World Data (RWD) and Real World Evidence (RWE). The deal positions OneMedNet to tap into the fastest-growing RWE solutions market in the Asia-Pacific region, driven by expanding healthcare data infrastructure. This move aligns with the projected growth of the RWE solutions market, which is expected to double by 2030.

Market Expansion
How OneMedNet’s entry into the Asia-Pacific region will impact its competitive positioning against other RWD providers.
Regulatory Dynamics
Whether the increasing acceptance of RWD and RWE by global regulators will accelerate OneMedNet’s growth.
Execution Risk
The pace at which OneMedNet can integrate and scale its data offerings with Mediplexus’s local expertise.